These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29758320)

  • 1. Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report.
    Nagumo Y; Maejima A; Toyoshima Y; Komiyama M; Yonemori K; Yoshida A; Fujimoto H
    Int J Surg Case Rep; 2018; 48():1-4. PubMed ID: 29758320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder.
    Hensley PJ; Bree KK; Guo CC; Lobo N; Campbell MT; Pettaway CA; Kamat AM
    BJU Int; 2022 Nov; 130(5):604-610. PubMed ID: 34773684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Myofibroblastic Tumour of the Urinary Bladder in a Middle-Aged Man-A Case Report of an Unusual Localization of a Rare Tumour.
    Prijovic N; Santric V; Babic U; Stankovic B; Acimovic M; Cekerevac M; Nikolic G; Cegar B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
    Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
    Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crizotinib in ALK
    Theilen TM; Soerensen J; Bochennek K; Becker M; Schwabe D; Rolle U; Klingebiel T; Lehrnbecher T
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
    Schöffski P; Kubickova M; Wozniak A; Blay JY; Strauss SJ; Stacchiotti S; Switaj T; Bücklein V; Leahy MG; Italiano A; Isambert N; Debiec-Rychter M; Sciot R; Lee CJ; Speetjens FM; Nzokirantevye A; Neven A; Kasper B
    Eur J Cancer; 2021 Oct; 156():12-23. PubMed ID: 34392187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK Gene Translocation in Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report.
    Takagi K; Takai M; Kameyama K; Horie K; Kikuchi M; Kato T; Mizutani K; Seike K; Tsuchiya T; Yasuda M; Yokoi S; Suzui N; Nakano M; Deguchi T
    Urol Case Rep; 2015 Sep; 3(5):138-40. PubMed ID: 26793530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robot-assisted Partial Cystectomy for Treatment of Inflammatory Myofibroblastic Tumor of the Bladder.
    Rotenberry C; Dowd K; Russell D; DeRiese W; Teeple S; Cammack T
    Urol Case Rep; 2017 Feb; 11():25-27. PubMed ID: 28083481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors.
    Lowe E; Mossé YP
    Oncol Ther; 2024 Jun; 12(2):247-255. PubMed ID: 38676786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locally Advanced Inflammatory Myofibroblastic Tumor Treated With Targeted Therapy: A Case Report and Literature Review.
    Durham C; Clemons M; Alias A; Konduri K
    Cureus; 2022 Jul; 14(7):e27223. PubMed ID: 36035049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation.
    Ogata M; Hatachi Y; Ogata T; Satake H; Imai Y; Yasui H
    Intern Med; 2019 Apr; 58(7):1029-1032. PubMed ID: 30449794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib.
    Liu W; Duan Q; Gong L; Yang Y; Huang Z; Guo H; Niu X
    Invest New Drugs; 2021 Feb; 39(1):278-282. PubMed ID: 32915420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory myofibroblastic tumor of the urinary bladder with FN1‑ALK gene fusion: A case report.
    Son SM; Woo CG; Lee OJ; Kim YJ; Lee HC
    Oncol Lett; 2023 Jun; 25(6):227. PubMed ID: 37153035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case Report.
    Comandini D; Catalano F; Grassi M; Pesola G; Bertulli R; Guadagno A; Spina B; Mascherini M; De Cian F; Pistoia F; Rebuzzi SE
    Front Oncol; 2021; 11():658327. PubMed ID: 34211840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Inflammatory Myofibroblastic Tumor of Urinary Bladder].
    Tanaka K; Ikeda A; Miyakawa T; Komine M; Tsutsumi M; Ishikawa S; Kawai K; Nishiyama H
    Hinyokika Kiyo; 2016 Apr; 62(4):201-4. PubMed ID: 27217015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare huge bladder inflammatory myofibroblastic tumor treated by en bloc resection with diode laser: a case report and literature review.
    Yuan H; Wang Z; Sun J; Chu J; Duan S; Wang M
    Front Oncol; 2024; 14():1327899. PubMed ID: 38529377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Clinical response to anaplastic lymphoma kinase inhibitor-based targeted therapy in uterine inflammatory myofibroblastic tumor harboring
    Zhao T; Zhang X; Liu X; Ren M; Cheng Y; Wang J; Luo Z
    Front Oncol; 2023; 13():1147974. PubMed ID: 37035208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel treatment of endobronchial inflammatory myofibroblastic tumor in a child.
    Reyes-Angel J; Rapkin LB; Simons JP; Muzumdar H
    Pediatr Pulmonol; 2022 Jan; 57(1):330-332. PubMed ID: 34710285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.
    Honda K; Kadowaki S; Kato K; Hanai N; Hasegawa Y; Yatabe Y; Muro K
    Invest New Drugs; 2019 Aug; 37(4):791-795. PubMed ID: 30790150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations.
    Debonis SA; Bongiovanni A; Pieri F; Fausti V; De Vita A; Riva N; Gurrieri L; Vanni S; Diano D; Mercatali L; Ibrahim T
    Medicine (Baltimore); 2021 May; 100(20):e25972. PubMed ID: 34011083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.